Alameda, California — According to state and local development sources, Vivani Medical plans to invest $1,606,500.00 to build out new space in Alameda. The company plans to occupy the new space at 1350 South Loop Rd, in Alameda, on or about November 1, 2023. According to the company website Vivani leverages proprietary technologies to develop and commercialize drug and device implants, including its lead asset NPM-119 (exenatide implant), which seeks to treat patients with chronic diseases with high unmet medical need. Through miniaturized, long-term biopharmaceutical implants, we seek to free patients from medication adherence challenges, minimizing the burden and maximizing the benefit of clinical treatments. Operating under our Biopharm Division and Neuromodulation Division, Vivani develops, manufactures, and markets therapies that target chronic conditions with high unmet medical needs. Our primary focus is advancing our portfolio of novel, long-term drug implant candidates by leveraging our proprietary NanoPortal technology to address medication adherence and help patients realize the full potential benefits of their medicines.

To learn more about Vivani Medical, visit http://vivani.com/

Company Contact:
Adam Mendelsohn, Chief Executive Officer
https://www.linkedin.com/in/adam-mendelsohn-64942b1/
415-506-8462

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.